Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States

Filetype[PDF-6.23 MB]


Select the Download button to view the document
This document is over 5mb in size and cannot be previewed
English
Details Supporting Files You May Also Like

Details:

  • Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
  • Content Notes:
    Purpose -- COVID-19 vaccines -- Groups recommended for vaccination -- Primary series -- Booster dose -- Guidance for COVID-19 vaccination for people who are moderately or severely immunocompromised -- Interchangeability of COVID-19 vaccine products -- Coadministration of COVID-19 vaccines with other vaccines -- COVID-19 vaccination and SARS-CoV-2 infection -- Vaccinating people with a known COVID-19 exposure or during COVID-19 outbreaks -- Considerations involving pregnancy, lactation, and fertility -- Vaccination of children and adolescents -- Patient counseling -- Considerations for mRNA COVID-19 vaccines: Pfizer-BioNTech and Moderna -- Considerations for Janssen COVID-19 Vaccine -- Contraindications and precautions -- Reporting of vaccine adverse events -- Laboratory testing -- Appendix A. Vaccine administration errors and deviations -- Appendix B. Guidance for People who are Moderately or Severely Immunocompromised and Vaccinated with Janssen COVID-19 Vaccine -- Appendix C: Triage of people with a history of allergies or allergic reactions -- Appendix D: Ingredients included in COVID-19 vaccines -- Appendix E. People who received COVID-19 vaccine outside the United States -- Appendix F. People.
  • Subjects:
  • Document Type:
    Webpage
  • Place as Subject:
    United States
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov